Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
Background Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment
of inflammatory bowel disease. Aims To determine the efficacy and safety of JAK inhibitors …
of inflammatory bowel disease. Aims To determine the efficacy and safety of JAK inhibitors …
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease.
C Ma, JK Lee, AR Mitra, A Teriaky… - Alimentary …, 2019 - europepmc.org
BACKGROUND: Janus kinase (JAK) inhibitors represent a novel therapeutic class for
treatment of inflammatory bowel disease. AIMS: To determine the efficacy and safety of JAK …
treatment of inflammatory bowel disease. AIMS: To determine the efficacy and safety of JAK …
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
C Ma, JK Lee, AR Mitra, A Teriaky… - Alimentary …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment
of inflammatory bowel disease. Aims To determine the efficacy and safety of JAK inhibitors …
of inflammatory bowel disease. Aims To determine the efficacy and safety of JAK inhibitors …
Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease.
D Choudhary, R Panaccione, C Ma… - Alimentary …, 2019 - search.ebscohost.com
Background: Janus kinase (JAK) inhibitors represent a novel therapeutic class for treatment
of inflammatory bowel disease. Aims: To determine the efficacy and safety of JAK inhibitors …
of inflammatory bowel disease. Aims: To determine the efficacy and safety of JAK inhibitors …